Lineage Cell Therapeutics, Inc. - Common Stock (LCTX)

CUSIP: 53566P109

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+2,237,919
Put/Call ratio
38%
SEC-reported price per share
$0.45
Number of holders
126
Value change
+$369,638
Number of buys
55
Open additional details 1 more signal available
Number of sells
35
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
248,782,811

Security key

53566P109

Report period

Q1 2025

Institutions

126

Top holders

10

Ownership snapshot

Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BROADWOOD PARTNERS, L.P.
Disclosed value leader
BROADWOOD PARTNERS, L.P.
Comparable rows
0/15
Latest evidence
27 Jan 2025
3/4/5 13F Highest disclosed value: $75,332,708 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BROADWOOD PARTNERS, L.P. has the largest disclosed position value at $75.33M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BROADWOOD PARTNERS, L.P.'s linked filing trail.
Disclosed position value Top 5
BROADWOOD PARTNERS, L.P. $75.33M
BROADWOOD CAPITAL INC $20.94M
BlackRock, Inc. $5.07M
VANGUARD GROUP INC $4.34M
PERCEPTIVE ADVISORS LLC $3.64M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BROADWOOD PARTNERS, L.P.
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$75,332,708
114,911,458 shares
mixed-class rows
— 27 Jan 2025
BROADWOOD CAPITAL INC
13F
Company
13F
—
denominator unverified
$20,937,293
41,666,255 shares
— 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$5,072,576
10,094,677 shares
— 31 Dec 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$4,342,363
8,632,928 shares
— 31 Dec 2024
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$3,636,514
7,236,843 shares
— 31 Dec 2024
Defender Capital, LLC.
13F
Company
13F
—
denominator unverified
$2,996,582
5,963,348 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
126
Shares
109,349,495
Rows available
126
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
126
Q1 2025 holders
126
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .